Disclosures under Regulation 31(1)/31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
DETAILS OF | PROMOTER HOLDING | PROMOTER HOLDING | DETAILS OF EVENTS | POST EVENT HOLDING | |||||||||
NAME(S) OF | EVENTS | IN THE TARGET | ALREADY | PERTAINING TO | OF ENCUMBERED | ||||||||
TYPE OF | PERTAINING TO | COMPANY | ENCUMBERED | ENCUMBRANCE | SHARES | ||||||||
PROMOTER | |||||||||||||
COMPANY | REGULATION | AND/OR | EVENT - | ENCUMBRANCE - | % OF | % OF | % OF | % OF | |||||
SYMBOL | CREATION/REL | DATE OF | |||||||||||
NAME | TYPE | PERSONS IN | EASE/INVOCAT | CREATION/ | TOTAL | TOTAL | TOTAL | TOTAL | |||||
PROMOTER | ION | RELEASE/ | NUMBER | EQUITY | NUMBER | EQUITY | NUMBER | EQUITY | NUMBER | EQUITY | |||
GROUP | INVOCATION OF | SHARE | SHARE | SHARE | SHARE | ||||||||
ENCUMBRANCE | CAPITAL | CAPITAL | CAPITAL | CAPITAL | |||||||||
MEDICAM | Medicamen | MANJU | |||||||||||
Biotech | 31(1) | Creation | 07-Jun-2022 | 70000 | 0.57 | 50000 | 0.41 | 20000 | 0.16 | 70000 | 0.57 | ||
EQ | BANSAL | ||||||||||||
Limited | |||||||||||||
Disclaimer: SEBI Circular dated Mar 7, 2022 with regards to Automation of disclosure requirements under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ("SAST Regulations")-System Driven Disclosures - Ease of doing business, as per circular point 8(iii) require the Stock Exchanges to disseminate on its website the disclosures required under SAST Regulations and received from the depositories, in a pdf format. The data/information displayed in this pdf file is based on the reports received from depositories and hence, the Exchange will not be responsible for any inaccurate/incorrect data/information. In case any discrepancy is noticed, the same can be informed to Listed companies, Stock Exchanges and Depositories